U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C80H106Cl2N11O27P
Molecular Weight 1755.635
Optical Activity UNSPECIFIED
Defined Stereocenters 18 / 18
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TELAVANCIN

SMILES

CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC3=C4OC5=CC=C(C=C5Cl)[C@@H](O)[C@@H]6NC(=O)[C@H](NC(=O)[C@@H]7NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C8=CC(Cl)=C(OC3=CC7=C4)C=C8)C9=CC(=C(O)C=C9)C%10=C(O)C(CNCP(O)(O)=O)=C(O)C=C%10[C@H](NC6=O)C(O)=O)O[C@@H](C)[C@H]1O

InChI

InChIKey=ONUMZHGUFYIKPM-MXNFEBESSA-N
InChI=1S/C80H106Cl2N11O27P/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114)/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-/m0/s1

HIDE SMILES / InChI

Approval Year

Condition Info

Condition Info

ConditionModalityTargetsHighest PhaseProduct
Primary
VIBATIV
Name Type Language
TELAVANCIN
DASH   INN   MART.   MI   VANDF   WHO-DD  
INN  
Official Name English
TELEVANCIN [VANDF]
Common Name English
TELEVANCIN
VANDF  
Common Name English
TELAVANCIN [MART.]
Common Name English
TELAVANCIN [WHO-DD]
Common Name English
TELAVANCIN [MI]
Common Name English
TELAVANCIN [VANDF]
Common Name English
TELAVANCIN [INN]
Common Name English
VANCOMYCIN, N(SUP 3'')-(2-(DECYLAMINO)ETHYL)-29-(((PHOSPHONOMETHYL)AMINO)METHYL)-
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS VIBATIV (AUTHORIZED: CROSS INFECTION PNEUMONIA, BACTERIAL)
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
NDF-RT N0000191281
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
WHO-ATC J01XA03
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
LIVERTOX 927
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
WHO-VATC QJ01XA03
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
Code System Code Type Description
MESH
C487637
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
INN
8504
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
WIKIPEDIA
TELAVANCIN
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
MERCK INDEX
M10527
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY Merck Index
NCI_THESAURUS
C87603
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
LactMed
372151-71-8
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
ChEMBL
CHEMBL507870
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
HSDB
372151-71-8
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
CAS
372151-71-8
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
DRUG BANK
DB06402
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
NDF-RT
N0000191280
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY Lipoglycopeptides [Chemical/Ingredient]
EVMPD
SUB26698
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY
RXCUI
473837
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY RxNorm
PUBCHEM
3081362
Created by admin on Tue Mar 06 11:15:41 UTC 2018 , Edited by admin on Tue Mar 06 11:15:41 UTC 2018
PRIMARY SWITZERF